Nasal Vaccines: Global Markets and Pipeline Analysis

Report Code: PHM268A

Publish Date: Jan 2023

Publisher: BCC Publishing

Category: Pharmaceuticals

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for nasal vaccines is estimated to increase from $383.8 million in 2022 to reach $568.1 million by 2027, at a compound annual growth rate (CAGR) of 8.2% from 2022 through 2027.

Report Includes

  • 23 data tables and 27 additional tables
  • A comprehensive overview and up-to-date analysis of the global market for nasal vaccines
  • Analyses of the global market trends, with historic market revenue data (sales figures) for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the upcoming market opportunities and trends driving and restricting growth of the global nasal vaccines market and its sub-segments, and the major regions and countries involved in market developments
  • Estimation of the actual market size and revenue forecast for the global nasal vaccines market in USD millions, and its corresponding market share analysis by vaccine type, dosage form, patient group, end-user, and region
  • Discussion of new developments in the nasal vaccines market, underlying clinical trials for all phases and list of vaccines, and their regulatory approvals etc.
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
  • Review of the new announcements, approvals, FDA clearances, partnerships and collaborations in the global nasal vaccines market
  • Detailed company profiles of the leading industry players, including AstraZeneca plc, BioDiem Ltd., BlueWillow Biologics, Meissa Vaccines Inc., and Serum Institute of India Pvt., Ltd.

Report Scope

This report examines trends and sales in the global market for nasal vaccines through 2027. Leaders in the industry and their vaccine portfolios, the need for nasal vaccine development, competitive intelligence and regional trends are discussed. The report includes a PESTEL analysis, that forms in part the base data for qualitative analysis and market estimates.

The report examines all forms of nasal vaccines, such as nasal drops or sprays, but excludes intramuscular and oral vaccines. The report discusses nasal vaccines by type, such as live-attenuated, inactivated, protein subunit and viral vectors. The application areas covered include pediatric and adult. Primary care clinics, hospitals, pharmacies and others are the end-user segments covered.

A $ in front of an amount indicates U.S. dollars unless stated otherwise.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $358.0 million
Market size forecast $568.1 million
Growth rate CAGR of 8.2% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered By Vaccine Type, Dosage Form, Patient Group, End User, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers
  • Rising Incidence of Respiratory Infections
  • Cost-Effective Alternative to Mainstream Vaccines
  • Increased Government Support and Favorable Regulations
  • Rising Awareness of the Need for Vaccination Programs
  • Growing Investments in R&D of Nasal Vaccines
Companies studied
ASTRAZENECABHARAT BIOTECH INTERNATIONAL LTD.
BIODIEM LTD.BLUEWILLOW BIOLOGICS INC.
CODAGENIX INC.CHANGCHUN BCHT BIOTECHNOLOGY CO.
CYANVAC LLC.INTRAVACC LLC.
MEISSA VACCINES INC.RAZI VACCINE AND SERUM RESEARCH INSTITUTE
SERUM INSTITUTE OF INDIA PVT. LTD.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global market for nasal vaccines is estimated at $383.8 million in 2022 and is expected to grow at a CAGR of 8.2% to nearly $568.1 million by 2027.
The key factors driving the growth of nasal vaccines market include increasing incidence of respiratory infections, rising awareness regarding vaccination programs, favorable government support and regulations, and growing investments by leading manufacturers in research and development of nasal vaccines among others.
The nasal vaccines market is segmented based on type, dosage form, application, end-user and region.
Pediatric nasal vaccines segment will dominate the market by the end of 2027.
Key companies in the market includes Bharat Biotech, AstraZeneca, Serum Institute of India, Changchun BCHT Biotechnology Co. (China), Meissa Vaccines, Codagenix, Inc., and CyanVac among others.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Nasal Vaccines: Global Markets and Pipeline Analysis78Free
Chapter- 1: Introduction8Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market Overview11Free
Chapter- 4: Pipeline Analysis of Nasal Vaccines6Free
Chapter- 5: Global Market for Nasal Vaccines by Type4Free
Chapter- 6: Global Market for Nasal Vaccines by Dosage Form4Free
Chapter- 7: Global Market for Nasal Vaccines by Patient Group4Free
Chapter- 8: Global Market for Nasal Vaccines by End User5Free
Chapter- 9: Global Market for Nasal Vaccines by Region10Free
Chapter- 10: Competitive Landscape5Free
Chapter- 11: Company Profiles18Free

Related Reports

Global Markets for Vaccine Technologies

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM014K

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

Pediatric Vaccines: Global Markets

Published - Oct 2022 | Publisher - BCC Publishing | Code - PHM265A

The global pediatric vaccines market should reach $34.5 billion by 2022 and more than $50.2 billion by 2027, with a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2022-2027.

Influenza Vaccines: Global Markets

Published - Jun 2022 | Publisher - BCC Publishing | Code - BIO230A

The global influenza vaccines market is estimated to increase from $6.9 billion in 2021 to $10.1 billion by 2026, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2021-2026.

DNA Vaccines: Technologies and Global Markets

Published - Sep 2021 | Publisher - BCC Publishing | Code - BIO067C

The global market for DNA vaccines should grow from $3.1 billion in 2021 to $11.5 billion by 2026 with a compound annual growth rate (CAGR) of 30.1% for the period of 2021-2026.

Recent Reports

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - PHM046D

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Global Markets for Vaccine Technologies

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM014K

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

Chagas Disease: American trypanosomiasis Market

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM282A

The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Nasal Vaccines: Global Markets and Pipeline Analysis
Sample Report